Meet your next partner or investor.

You will meet a “who’s who” of the biopharma industry, including executives and investors from:

  • ABL Bio
  • Accelerator Life Science Partners (ALSP)
  • ALTEOGEN
  • Akeylink Biotechnology
  • AN Ventures
  • Angelini Ventures
  • Argonaut Bio
  • Asahi Kasei Pharma
  • Bayer
  • Biocytogen
  • Boehringer Ingelheim
  • Brandon Capital
  • Candid Therapeutics
  • CBC Group
  • CHA Bio Group
  • ClavystBio
  • CR-CP Life Science Fund
  • Daewon Pharmaceutical
  • Dong-A
  • Eli Lilly and Company
  • Fast Track Initiative
  • Flagship Pioneering
  • GC Biopharma
  • GSK
  • Hillgene
  • Hong Kong Life Science Investment Association
  • HUGEL
  • Ildong Pharmaceutical
  • IMM Investment
  • iPark Institute
  • Japan Bioindustry Association (JBA)
  • Johnson & Johnson
  • K2 Therapeutics
  • Kolon Tissuegene
  • Korea Biotechnology Industry Organization (KoreaBIO)
  • Korea Investment Partners (KIP)
  • Kurma Partners
  • Lake Bleu Capital
  • LG Chem
  • LigaChem Biosciences
  • LOTTE Biologics
  • LYFE Capital
  • McKinsey & Company
  • MedPacto
  • Merck Group
  • MPM BioImpact
  • MSD
  • MSQ Ventures
  • Novartis
  • Novo Holdings
  • Orum Therapeutics
  • Pacific Bridge
  • PharmAbcine
  • Panacea Venture
  • RA Capital
  • Roche
  • Samsung Biologics
  • Samsung Bioepis
  • Samsung Medical Center
  • Samyang Biopharm
  • Sanofi
  • Seoul BioHub
  • Serica Partners
  • SK Biopharmaceuticals
  • Solasta Ventures
  • Taiwan Bio Industry Organization (Taiwan BIO)
  • Woori Venture Partners
  • Yuhan
  • And many more...